Comparison of serum apolipoprotein A-I between Chinese multiple sclerosis and other related autoimmune disease

Table 2 Analysis of serum apoA-I in all male or female patients.

	MS	CIS	GBS	Viral encephalits	SLE	RA	Healthy controls
Female	32	38	28	26	22	20	27
Mean age ± SD*	35.7 ± 14.2	31.2 ± 17.3	29.6 ± 19.9	27.2 ± 13.6	31.4 ± 8.57	35.1 ± 7.75	38.1 ± 14.3
apoA-I (g/L)	1.516 ± 0.057	1.368 ± 0.073	1.321 ± 0.101	1.243 ± 0.064	0.897 ± 0.068	1.107 ± 0.072	1.230 ± 0.062
P **	0	0.114	0.097	0.002	0.000	0.000	0.001
Male	28	19	10	25	14	15	32
Mean age ± SD*	36.0 ± 15.6	40.7 ± 18.5	39.9 ± 19.7	30.1 ± 13.8	31.9 ± 13.7	37.9 ± 12.1	33.8 ± 4.11
apoA-I (g/L)	1.263 ± 0.075	1.422 ± 0.091	1.260 ± 0.093	1.062 ± 0.080	0.979 ± 0.106	0.963 ± 0.102	1.112 ± 0.070
P**	0	0.954	0.194	0.001	0.000	0.000	0.001

Data are means ± SD. * Significant different, multivarite ANOVA, P = 0.159 (P > 0.05). There was no significant effect of age on female or male serum apoA-I levels in different disease groups. **Compared serum apoA-I levels of between male/female MS patients and male/female patients in other groups, patients with autoimmune demyelinating diseases had higher serum apoA-I levels than other patients and healthy subjects.

ISSN: 1476-511X